Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimal stimulation IVF pilot study for infertility
ACTRN12612000740897Phase 4Recruiting
- Sponsor
- Adelaide Fertility Centre
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of clomiphene, corifollitropin alfa, ganirelix and recombinant human chorionic gonadotrophin in infertility (2 arms), sponsored by Adelaide Fertility Centre. Primary endpoint: Clinical pregnancy rate. Started Jul 2012; status: recruiting.
02
Drugs
clomiphenecorifollitropin alfaganirelixrecombinant human chorionic gonadotrophin
03
Conditions
infertility
Beyond the preview
Go deeper on ACTRN12612000740897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000740897.